メチシリン耐性黄色ブドウ球菌 (MRSA)薬の世界市場：インサイト・予測

• 英文タイトル：Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Insights, Forecast to 2025

• レポートコード：QYR9ST02951 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※本調査レポートでは、世界のメチシリン耐性黄色ブドウ球菌 (MRSA)薬市場について調査・分析し、以下の構成でお届け致します。メチシリン耐性黄色ブドウ球菌 (MRSA)薬の種類別には、合成医薬品、半合成に、用途別には、経口投与、非経口に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別メチシリン耐性黄色ブドウ球菌 (MRSA)薬売上データ ・地域別メチシリン耐性黄色ブドウ球菌 (MRSA)薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別メチシリン耐性黄色ブドウ球菌 (MRSA)薬市場規模：合成医薬品、半合成 ・用途別メチシリン耐性黄色ブドウ球菌 (MRSA)薬市場規模：経口投与、非経口 ・主要メーカーの企業情報：Theravance Biopharma、Basilea Pharmaceutica、Pfizer、Debiopharm Group、Merck、Allergan、Melinta Therapeutics、AmpliPhi Biosciences Corporation、KYORIN Pharmaceutical.、Baxter International ・メチシリン耐性黄色ブドウ球菌 (MRSA)薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ...

Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs in these regions.
This research report categorizes the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market by top players/brands, region, type and end user. This report also studies the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Theravance Biopharma
Basilea Pharmaceutica
Pfizer
Debiopharm Group
Merck
Allergan
Melinta Therapeutics
AmpliPhi Biosciences Corporation
KYORIN Pharmaceutical.
Baxter International

Market size by Product
Synthetic Drugs
Semisynthetic
Market size by End User
Oral Administration
Parenteral

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Study Coverage
1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Product
1.4.2 Synthetic Drugs
1.4.3 Semisynthetic
1.5 Market by End User
1.5.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by End User
1.5.2 Oral Administration
1.5.3 Parenteral
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size
2.1.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue 2014-2025
2.1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales 2014-2025
2.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Growth Rate by Regions
2.2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Regions
2.2.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers
3.1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers
3.1.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Manufacturers
3.1.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers
3.2.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Manufacturers
3.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product
4.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Product
4.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Breakdown Data by End User

6 North America
6.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
6.1.1 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
6.1.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
6.3 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User

7 Europe
7.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
7.1.1 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
7.1.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
7.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User

8 Asia Pacific
8.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
8.1.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
8.1.2 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
8.3 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User

9 Central & South America
9.1 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
9.1.1 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
9.1.2 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
9.3 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Countries
10.1.1 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries
10.1.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by Product
10.3 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs by End User

11 Company Profiles
11.1 Theravance Biopharma
11.1.1 Theravance Biopharma Company Details
11.1.2 Company Business Overview
11.1.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.1.5 Theravance Biopharma Recent Development
11.2 Basilea Pharmaceutica
11.2.1 Basilea Pharmaceutica Company Details
11.2.2 Company Business Overview
11.2.3 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.2.5 Basilea Pharmaceutica Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.3.5 Pfizer Recent Development
11.4 Debiopharm Group
11.4.1 Debiopharm Group Company Details
11.4.2 Company Business Overview
11.4.3 Debiopharm Group Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Debiopharm Group Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.4.5 Debiopharm Group Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Company Business Overview
11.5.3 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.5.5 Merck Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Company Business Overview
11.6.3 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.6.5 Allergan Recent Development
11.7 Melinta Therapeutics
11.7.1 Melinta Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Melinta Therapeutics Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Melinta Therapeutics Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.7.5 Melinta Therapeutics Recent Development
11.8 AmpliPhi Biosciences Corporation
11.8.1 AmpliPhi Biosciences Corporation Company Details
11.8.2 Company Business Overview
11.8.3 AmpliPhi Biosciences Corporation Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 AmpliPhi Biosciences Corporation Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.8.5 AmpliPhi Biosciences Corporation Recent Development
11.9 KYORIN Pharmaceutical.
11.9.1 KYORIN Pharmaceutical. Company Details
11.9.2 Company Business Overview
11.9.3 KYORIN Pharmaceutical. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 KYORIN Pharmaceutical. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.9.5 KYORIN Pharmaceutical. Recent Development
11.10 Baxter International
11.10.1 Baxter International Company Details
11.10.2 Company Business Overview
11.10.3 Baxter International Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Baxter International Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.10.5 Baxter International Recent Development

12 Future Forecast
12.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by Regions
12.1.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Regions 2019-2025
12.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by Product
12.2.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Product 2019-2025
12.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Forecast by End User
12.4 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
12.5 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
12.6 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
12.7 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast
12.8 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Picture
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Segments
Table Key Manufacturers Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Covered
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product 2014-2025
Figure Synthetic Drugs Product Picture
Table Major Manufacturers of Synthetic Drugs
Figure Semisynthetic Product Picture
Table Major Manufacturers of Semisynthetic
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oral Administration
Figure Parenteral
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Report Years Considered
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size 2014-2025 (Million US$)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales 2014-2025 (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Regions 2014-2019 (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Regions 2014-2019
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Regions
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Regions
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Manufacturers (2014-2019)
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price (2014-2019) (USD/Unit)
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Type
Table Date of International Manufacturers Enter into Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Product (2014-2019)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product in 2018
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Product (2014-2019)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Product (2014-2019)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Product in 2018
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by End User (2014-2019)
Figure Global Sales Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User (2014-2019)
Figure Global Sales Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User in 2018
Figure North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries (2014-2019) (K Units)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Product
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User
Figure Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries
Figure Germany Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Product
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User
Figure Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Product
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User
Figure Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries
Figure Brazil Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Product
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User
Figure Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Countries
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Countries
Figure GCC Countries Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Product
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by End User
Table Theravance Biopharma Company Details
Table Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Theravance Biopharma Recent Development

Table Basilea Pharmaceutica Company Details
Table Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Basilea Pharmaceutica Recent Development

Table Pfizer Company Details
Table Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Debiopharm Group Company Details
Table Debiopharm Group Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Debiopharm Group Recent Development

Table Merck Company Details
Table Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Allergan Company Details
Table Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development

Table Melinta Therapeutics Company Details
Table Melinta Therapeutics Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Melinta Therapeutics Recent Development

Table AmpliPhi Biosciences Corporation Company Details
Table AmpliPhi Biosciences Corporation Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AmpliPhi Biosciences Corporation Recent Development

Table KYORIN Pharmaceutical. Company Details
Table KYORIN Pharmaceutical. Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table KYORIN Pharmaceutical. Recent Development

Table Baxter International Company Details
Table Baxter International Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Baxter International Recent Development

Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Value Chain
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Customers List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---